95 filings
Page 4 of 5
8-K
9t1nn xg63
2 Apr 18
Novus Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update
12:00am
8-K
qrzah6ki43nua
12 Mar 18
Other Events
12:00am
8-K
c257opzxhk
29 Nov 17
Results of Operations and Financial Condition
12:00am
8-K
tfpmk6mwxq8flrud01y8
8 Nov 17
Novus Therapeutics Reports Third Quarter 2017 Results
12:00am
8-K
qgezsnfg
6 Nov 17
Departure of Directors or Certain Officers
12:00am
8-K
e8hv4242v1p4oz0rab7v
29 Sep 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
3tf2 xyj8ereu5c3o53n
22 Aug 17
Entry into a Material Definitive Agreement
12:00am
8-K
vn4hzfhycxd1 y02q0bh
10 Aug 17
Novus Therapeutics Reports Second Quarter 2017 Results
12:00am
8-K/A
6ihzmoym85i7mqz04
25 Jul 17
Index to Unaudited Interim Financial Statements
12:00am
8-K
6jumxs
10 Jul 17
Departure of Directors or Certain Officers
12:00am
8-K
hshjwsq
31 May 17
Departure of Directors or Certain Officers
12:00am
8-K
hrit5amp2q cdm8e
15 May 17
Entry into a Material Definitive Agreement
12:00am
8-K
un6gltdsa969guuir
28 Apr 17
Other Events
12:00am
8-K
lmec8y8lh
9 Mar 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
8dfvz0krgln79t3 huy
3 Feb 17
Entry into a Material Definitive Agreement
12:00am
8-K
mvtggej6s nej7ncwo
22 Dec 16
Tokai Pharmaceuticals and Otic Pharma Enter into Share Purchase Agreement
12:00am
8-K
xag1f9322 6cmz8890bj
12 Oct 16
Departure of Directors or Certain Officers
12:00am
8-K
5hvsc4iftmn99k9l
22 Aug 16
Regulation FD Disclosure
12:00am
8-K
0um 1ask1y4l7
3 Aug 16
Cost Associated with Exit or Disposal Activities
12:00am
8-K
c5lgy64yzyohhlm8
26 Jul 16
Results of Operations and Financial Condition
12:00am